Hikma Pharmaceuticals Plc Director/PDMR Shareholding (3051A)

TIDMHIK

RNS Number : 3051A

Hikma Pharmaceuticals Plc

23 March 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities

The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the disposal of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by the Chief Strategy and Corporate Development Officer. This announcement is made in accordance with article 19.3 of MAR.

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  ------------------------------------------------------------------ 
 a)   Name                   Bassam Kanaan 
---  ---------------------  ------------------------------------------- 
 2    Reason for the notification 
---  ------------------------------------------------------------------ 
 a)   Position/status        Chief Strategy and Corporate Development 
                              Officer / PDMR 
---  ---------------------  ------------------------------------------- 
 b)   Initial notification   Initial notification 
       /Amendment 
---  ---------------------  ------------------------------------------- 
 3    Details of the issuer, emission allowance market 
       participant, auction platform, auctioneer or 
       auction monitor 
---  ------------------------------------------------------------------ 
 a)   Name                   Hikma Pharmaceuticals PLC 
---  ---------------------  ------------------------------------------- 
 b)   LEI                    549300BNS685UXH4JI75 
---  ---------------------  ------------------------------------------- 
 4    Details of the transaction(s): section to be 
       repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; 
       and (iv) each place where transactions have 
       been conducted 
---  ------------------------------------------------------------------ 
 a)   Description            Description: Ordinary shares of 10 
       of the financial       pence each 
       instrument,            ID Code: GB00B0LCW083 
       type of instrument 
       and identification 
       code 
---  ---------------------  ------------------------------------------- 
 b)   Nature of              Disposal of 43,000 Ordinary Shares 
       the transaction        of 10 pence each in Hikma Pharmaceuticals 
                              PLC. 
---  ---------------------  ------------------------------------------- 
 c)   Price(s) and           Price(s): GBP21.22 
       volume(s)              Volume(s): 43,000 
---  ---------------------  ------------------------------------------- 
 d)   Aggregated             Aggregated volume: 43,000 
       information            Price: GBP21.22 
---  ---------------------  ------------------------------------------- 
 e)   Date of the            20 to 22 March 2017 
       transaction 
---  ---------------------  ------------------------------------------- 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
---  ---------------------  ------------------------------------------- 
 

Peter Speirs, Company Secretary, Responsible for releasing this announcement

23 March 2017

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHGCGDXCDDBGRX

(END) Dow Jones Newswires

March 23, 2017 05:30 ET (09:30 GMT)